Yangxinshi Tablets Versus Trimetazidine on Exercise Tolerance After Percutaneous Coronary Intervention: Rationale and Design of the Double-blind, Randomized HEARTRIP Trial

Yangxinshi Tablets Versus Trimetazidine on Exercise Tolerance After Percutaneous Coronary Intervention: Rationale and Design of the Double-blind, Randomized HEARTRIP Trial

Improving exercise tolerance is indisputably beneficial for long-term survival in patients treated with percutaneous coronary intervention (PCI). Although previous studies suggested that Yangxinshi tablets effectively improve exercise tolerance in patients with coronary heart disease, the evidence i...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yi Li, Jian Zhang, Hong Chen, Yi Zhang, Jing Li, Haichu Yu, Xiaoping Meng, Haitao Yuan, Lili Shao, Yaling Han
Format:	Article
Language:	English
Published:	Wolters Kluwer Health/LWW 2023-06-01
Series:	Cardiology Discovery
Online Access:	http://journals.lww.com/10.1097/CD9.0000000000000094
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

RATIONALE FOR APPLICATION, AND BENEFITS OF TRIMETAZIDINE IN HEART FAILURE BY ITS INFLUENCE OF MYOCARDIUM METABOLISM
by: Yu. M. Lopatin, et al.
Published: (2016-08-01)

Assessment of Trimetazidine Treatment in Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention
by: Xiuying Tang, et al.
Published: (2022-01-01)

Effects of Trimetazidine Pretreatment on Endothelial Dysfunction and Myocardial Injury in Unstable Angina Patients Undergoing Percutaneous Coronary Intervention
by: Shuai Shao, et al.
Published: (2019-01-01)

Pleiotropic effects of trimetazidine
by: O. V. Romashchenko, et al.
Published: (2013-08-01)

Evaluating the role of trimetazidine in preventing myocardial injury and contrast-induced nephropathy in patients undergoing percutaneous coronary interventions
by: Anshul Jain, et al.
Published: (2025-05-01)

ISCHEMIC SYNDROMES AND CYTOPROTECTION (TRIMETAZIDINE)
by: A. A. Gorbachenkov, et al.
Published: (2001-10-01)

AN EXPERIENCE OF TRIMETAZIDINE USAGE IN COMORBIDITY
by: I. V. Kochetkova, et al.
Published: (2018-04-01)

Rationale and Design of a Randomized Controlled Trial of Bivalirudin with a Prolonged High-Dose Infusion Versus Heparin Monotherapy During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction: The BRIGHT-4 Trial
by: Zhenyang Liang, et al.
Published: (2022-12-01)

Trimetazidine effects on mitochondria energetic activity
by: S. V. Eliseeva, et al.
Published: (2008-12-01)

CYTOPROTECTION WITH TRIMETAZIDINE MB: RECENT DATA
by: I. G. Gordeev, et al.
Published: (2015-05-01)

Synergistic interaction between trimetazidine and ketoprophen in mice
by: Daniela Carmen Ababei, et al.
Published: (2015-06-01)

Efficacy of Trimetazidine and Sulodexide in Patients with Microvascular Angina
by: S. A. Boldueva, et al.
Published: (2020-07-01)

THE USAGE OF TRIMETAZIDINE IN COMPLEX TREATMENT OF HEART FAILURE
by: N. R. Paleev, et al.
Published: (2001-04-01)

Effectiveness of the original trimetazidine MR in patients with stable coronary heart disease and angina attacks resistant to trimetazidine generics (ETALON study)
by: A. V. Fendrikova, et al.
Published: (2011-08-01)

The influence of trimetazidine hydrochloride on acute ischemia-reperfusion injury of endothelial cells and oxidative stress response of rat kidney
by: DU Yi, et al.
Published: (2017-01-01)

Effectiveness and Tolerability of Trimetazidine 80 mg Once Daily in Patients with Chronic Coronary Syndrome in Brazil: The V-GOOD Observational Study
by: Luís Henrique Wolff Gowdak, et al.
Published: (2025-04-01)

Cardioprotective Effect of Trimetazidine in Cardiac Contusion: Experimental Study
by: O. V. Korpacheva, et al.
Published: (2008-04-01)

CLINICAL EFFECTIVENESS OF THE MODIFIED RELEASE TRIMETAZIDINE IN MICROVASCULAR ANGINA
by: P. Yu. Galin, et al.
Published: (2016-12-01)

Trimetazidine MB treatment in patients with chronic heart failure
by: T. E. Morozova, et al.
Published: (2010-06-01)

Pharmacological treatment of stable angina pectoris: the place of trimetazidine
by: E. A. Temnikova
Published: (2022-12-01)

Is treatment with trimetazidine beneficial in patients with chronic heart failure?
by: Xiang Zhou, et al.
Published: (2014-01-01)

Antipsychotic-Like Effect of Trimetazidine in a Rodent Model
by: Oytun Erbaş, et al.
Published: (2013-01-01)

ADDITIONAL USE OF TRIMETAZIDINE IN PATIENTS WITH CHRONIC HEART FAILURE. A META-ANALYSIS
by: Lei Zhang, et al.
Published: (2015-12-01)

ANTIISCHEMIC METABOLIC MODULATOR TRIMETAZIDINE IN TREATMENT OF CORONARY HEART DISEASE
by: V. P. Lupanov
Published: (2017-02-01)

Predictive Value of Cardiopulmonary Exercise Testing Parameters in Patients under Percutaneous Coronary Intervention with High Pulse Pressure
by: Qiang Ren, et al.
Published: (2025-02-01)

Formulation Optimization and Quality Analysis of Dendrobium officinale Chewable Tablets
by: Wenyu ZHANG, et al.
Published: (2025-02-01)

Trimetazidine: Activating AMPK Signal to Ameliorate Coronary Microcirculation Dysfunction after Myocardial Infarction
by: Xiaolong Qu, et al.
Published: (2025-01-01)

MEMBRANE-SАVING ACTION OF TRIMETAZIDINE IN SUBJECTS WITH ACUTE MYOCARDIAL INFARCTION
by: S. V. Vasilyev, et al.
Published: (2014-12-01)

TRIMETAZIDINE AND MILDRONATE AS DIRECT ACTION Β2 - ADRENOSENSIBILIZERS (EXPERIMENTAL EVIDENCE)
by: V. I. Tsirkin, et al.
Published: (2002-02-01)

Effects of trimetazidine on oxidant-antioxidant balance and angiogenesis; an in vivo experimental study
by: Fethullah Kayan, et al.
Published: (2025-04-01)

Clinical effectiveness of trimetazidine as a leading cardiovascular drug with metabolic action
by: A. Yu. Gasparyan, et al.
Published: (2008-08-01)

Trimetazidine in chronic heart failure patients aged above 75 years
by: I. V. Ignatenko, et al.
Published: (1970-01-01)

EFFECTS OF TRIMETAZIDINE ON THE TRANSMITRAL BLOOD FLOW IN PATIENTS WITH DIASTOLIC HEART FAILURE
by: Yu. N. Fedulaev, et al.
Published: (2015-09-01)

Efficacy of trimetazidine for myocardial ischemia-reperfusion injury in rat models: a systematic review and meta-analysis
by: Xiaobin Zhang, et al.
Published: (2025-06-01)

Rationale and design of the randomised, controlled Percutaneous coronary intervention using Assisted Robotic TechnologY (PARTY) trial
by: Rohan Rajaratnam, et al.
Published: (2024-11-01)

THE STUDY ON TOLERABILITY AND EFFICACY OF THE NEW COMPLEX DRUG HELMINTAL TABLETS BASED ON MOXIDECTIN AND PRAZIQUANTEL
by: M. V. Arisov, et al.
Published: (2016-12-01)

Comparison of penetrating needles and non-penetrating needles with electrical stimulation combined with exercise training for relieving dyspnea and improving exercise tolerance in chronic obstructive pulmonary disease patients: A single-blind randomized controlled trial
by: Ying He, et al.
Published: (2025-03-01)

Techniques and Evidence for Percutaneous Coronary Intervention for Coronary Bifurcation Lesions: An Ongoing Journey
by: Yaling Han, et al.
Published: (2022-09-01)

Prognostic Analysis and an Appropriate Antiplatelet Strategy for Patients With Percutaneous Coronary Intervention and High Bleeding Risk: Rationale and Protocol for a Multi-Center Cohort Study
by: Junyan Zhang, et al.
Published: (2024-09-01)

Trimetazidine in coronary heart disease patients: mechanism of action and controlled trials’ results
by: L. V. Kremneva, et al.
Published: (2005-04-01)